| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/09/2011 | WO2011066651A1 Snalp formulations containing antioxidants |
| 06/09/2011 | WO2011027248A4 Oral liquid formulation comprising salbutamol and guaifenesin |
| 06/09/2011 | WO2011022291A3 Photoregulated reversible hydrogels for delivery and releasing of drugs and other therapeutical reagents |
| 06/09/2011 | US20110137285 Kit of tamponing liquids and a method for the treatment of tears and/or detachments of the retina using such liquids |
| 06/09/2011 | US20110137243 Coating On A Balloon Device |
| 06/09/2011 | US20110136922 Activation induced deaminase (aid) |
| 06/09/2011 | US20110136921 Sustained release composition |
| 06/09/2011 | US20110136919 Novel precipitated silicic acids for support applications |
| 06/09/2011 | US20110136912 Ophthalmic emulsion |
| 06/09/2011 | US20110136851 Sucralose Formulations To Mask Unpleasant Tastes |
| 06/09/2011 | US20110136847 High Concentration Formulations of Opioids and Opioid Derivatives |
| 06/09/2011 | US20110136744 Cyclosporin analog formulations |
| 06/09/2011 | US20110135927 Excipient for compressed tablets comprising novel spherical mannitol |
| 06/09/2011 | US20110135799 Thickened beverages for dysphagia |
| 06/09/2011 | US20110135752 Methods For Preserving Ophthalmic Solutions and Preserved Ophthalmic Solutions |
| 06/09/2011 | US20110135736 Compositions and Methods for Producing Vascular Occlusion using a Solid-phase Platelet Binding Agent |
| 06/09/2011 | US20110135732 Multiple phase cross-linked compositions and uses thereof |
| 06/09/2011 | US20110135731 Abuse-resistant opioid dosage form |
| 06/09/2011 | US20110135727 Hepatocyte Delivery Vehicle for Delivery of a Combination of Recombinant Human Regular Insulin and Recombinant Human Insulin Isophane to a Mammal |
| 06/09/2011 | US20110135725 Lipid Construct for Delivery of Insulin to a Mammal |
| 06/09/2011 | US20110135722 Pharmaceutical formulation comprising a proton pump inhibitor and antacids |
| 06/09/2011 | US20110135707 Polyhydroxyalkanoates for in vivo applications |
| 06/09/2011 | US20110135692 Anti-tumor immunotherapy |
| 06/09/2011 | US20110135684 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vitro |
| 06/09/2011 | US20110135660 Prevention and treatment of synucleinopathic disease |
| 06/09/2011 | US20110135639 B lymphocyte stimulator assays |
| 06/09/2011 | US20110135585 Complex, Emulsion Containing The Same, And Water-In-Oil Emulsion Cosmetic Containing The Same |
| 06/09/2011 | US20110135583 Anionic Isosorbide Derivatives and Their Use (II) |
| 06/09/2011 | US20110135568 Thickened beverages for dysphagia |
| 06/09/2011 | CA2782424A1 Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof |
| 06/09/2011 | CA2782333A1 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
| 06/09/2011 | CA2782194A1 Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy |
| 06/09/2011 | CA2781682A1 Multispecific antibodies, antibody analogs, compositions, and methods |
| 06/09/2011 | CA2781254A1 Carboxyvinyl polymer-containing nanoparticle suspensions |
| 06/09/2011 | CA2780304A1 Ophthalmic emulsion |
| 06/08/2011 | EP2330213A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/08/2011 | EP2330208A1 Nanoparticles comprising RNA ligands |
| 06/08/2011 | EP2330130A1 Human monoclonal antibodies against CD20 |
| 06/08/2011 | EP2330081A2 Oxidative reductive potential water solution, processes for producing same and methods of using the same |
| 06/08/2011 | EP2329861A1 Pharmaceutical products and compositions comprising formoterol, budesonide and ipratropium |
| 06/08/2011 | EP2329823A1 Method for improving absorbability of preparation, and preparation having improved absorbability |
| 06/08/2011 | EP2329814A1 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer |
| 06/08/2011 | EP2329813A1 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 06/08/2011 | EP2329717A1 Disinfectant and/or bactericidal aqueous compositions |
| 06/08/2011 | EP2328620A2 Active particles for bio-analytical applications and methods for their preparation |
| 06/08/2011 | EP2328619A2 Polymeric benzyl carbonate-derivatives |
| 06/08/2011 | EP2328618A2 Pharmaceutical composition of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4- oxoquinoline-3-carboxamide and administration thereof |
| 06/08/2011 | EP2328617A2 Carrier system for biological agents containing organosilicon compounds and uses thereof |
| 06/08/2011 | EP2328607A1 Stable formulation of a therapeutic protein |
| 06/08/2011 | EP2328554A1 Encapsulation of lipophilic or amphiphilic therapeutic agents in nano-emulsions |
| 06/08/2011 | EP2328551A1 Stabilized pharmaceutical sub-micron suspensions and methods of forming same |
| 06/08/2011 | EP2328550A1 Mucoadherents compositions and their use |
| 06/08/2011 | EP2040691B1 Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl]benzoic acid |
| 06/08/2011 | EP2004721B1 Novel o-carboxy anhydrides (ocas) comprising a salifiable function and polymers obtained from these ocas |
| 06/08/2011 | EP1907482B1 Hydrogen bonded hydrogels |
| 06/08/2011 | EP1573022B1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 06/08/2011 | EP1531800B1 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 06/08/2011 | EP1427427B1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/08/2011 | EP1392255B1 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof |
| 06/08/2011 | EP1320356B2 Preparation of vitamin emulsions and concentrates thereof |
| 06/08/2011 | EP1259259B1 Mucosal adjuvant formulation |
| 06/08/2011 | CN1895322B Jinganmin effervescent tablets and preparation thereof |
| 06/08/2011 | CN1882321B Pellets containing venlafaxine hydrochloride |
| 06/08/2011 | CN1744883B Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof |
| 06/08/2011 | CN102089431A Functionalized polypeptides |
| 06/08/2011 | CN102089241A Controllable synthesis of porous carbon spheres, and electrochemical applications thereof |
| 06/08/2011 | CN102089016A Implant and method for the manufacture thereof |
| 06/08/2011 | CN102089009A Conjugated Vi saccharides |
| 06/08/2011 | CN102089008A Manufacturing method of collagen gel composition for bone regeneration |
| 06/08/2011 | CN102088984A Eradicating agent and eradication method for helicobacter pylori |
| 06/08/2011 | CN102088981A Sialic acid to support salivation |
| 06/08/2011 | CN102088964A Electrostatically charged multi-acting nasal application, product, and method |
| 06/08/2011 | CN102088963A Encapsulation of biologically active agents |
| 06/08/2011 | CN102088960A Drug delivery carrier |
| 06/08/2011 | CN102088958A Methods and compositions for enhanced delivery of macromolecules |
| 06/08/2011 | CN102086266A Polypeptide-containing asymmetric hyperbranched amphoteric polyelectrolyte and preparation method thereof |
| 06/08/2011 | CN102086255A Nano hydroxyapatite hybrid material and preparation method thereof |
| 06/08/2011 | CN102085380A Preparation method of nano magnetic particles for detection and treatment of coronary heart diseases |
| 06/08/2011 | CN102085376A Phospholipid complex of gentian total glucosides and preparation method thereof |
| 06/08/2011 | CN102085375A In-situ magnetically-heated temperature-sensitive targeted nano drug carrier for reversal of multi-drug resistance in tumors |
| 06/08/2011 | CN102085374A Asarin medical composition, preparation method and application thereof |
| 06/08/2011 | CN102085363A Vibrio cholerae O139 capsular polysaccharide conjugate vaccine and preparation method thereof |
| 06/08/2011 | CN102085355A Liraglutide long-acting microsphere injection and preparation method thereof |
| 06/08/2011 | CN102085321A Drug dripping pill with effects of promoting digestion and eliminating retention |
| 06/08/2011 | CN102085305A Dripping pill capable of reducing fat |
| 06/08/2011 | CN102085276A Formula of traditional Chinese medicine freckle-removing cream and preparation method thereof |
| 06/08/2011 | CN102085270A Figwort dispersible tablet |
| 06/08/2011 | CN102085268A Rhizoma picrorrhiza dispersible tablet and preparation method thereof |
| 06/08/2011 | CN102085266A Anti-erosive suppository for treating gynecological infection and preparation method thereof |
| 06/08/2011 | CN102085258A Cream preparation for preventing and curing mammary gland hyperplasia and preparation method thereof |
| 06/08/2011 | CN102085238A Lipid preparation containing radix gentianae totalglycoside-phospholipid complexes and preparation method thereof |
| 06/08/2011 | CN102085228A Medicinal drop pills for treating menopause syndrome |
| 06/08/2011 | CN102085203A Ophthalmic preparation of levofloxacin and prednisolone acetate and preparation method thereof |
| 06/08/2011 | CN102085198A Transdermal delivery systems |
| 06/08/2011 | CN102085197A Venlafaxine slow-release preparation and preparation method thereof |
| 06/08/2011 | CN102085196A Nefopam hydrochloride bilayer slow-release tablet and preparation method thereof |
| 06/08/2011 | CN102085195A Metoprolol succinate sustained-release tablets and preparation method thereof |
| 06/08/2011 | CN102085194A Levetiracetam oral disintegrating tablet and preparation method thereof |
| 06/08/2011 | CN102085193A Tibolone orally disintegrating tablets and method for preparing same |
| 06/08/2011 | CN102085192A Rosuvastatin calcium oral disintegrating tablet and preparation method thereof |